Is Your Financial Advisor Working for You? Important Questions Might Give you the Answer Part II
The issue made headlines again in 2012, when a high-ranking Goldman Sachs employee resigned publicly through an Op-Ed piece in the New York Times, citing corporate culture as the primary reason for his departure. The employee stated, "the interests of the clients continue to be sidelined in the way the firm operates and thinks about making money." If this occurs at Goldman Sachs, whose clients include the most sophisticated financial firms in the world, it can certainly also occur at any physician’s chosen investment firm.
In the first piece of this two part article, we will provide two questions to ask your financial advisor. The intent is to help you gain a better understanding of how they make money from advising you and how they work for, or potentially against, you.
• Question 1: Does your advisor owe you a fiduciary duty as a client or are they held only to a "suitability" standard? Most physician investors are not aware of the fact that brokers and investment advisors are held to different standards when it comes to the duty they owe clients. Registered investment advisors such as OJM Group are held to a "fiduciary standard." This means we are required to make recommendations that are in a client's best interest. Contrast this duty to the suitability requirement that dictates that brokers are simply required to make recommendations that are suitable based on the facts at the time of the interaction. On the surface, this may seem like a subtle difference, however the end result can have a substantial impact on the client.
Example: Client A contacts his broker and expresses an interest in investing $50,000 in U.S. growth stocks. The broker invests the client assets in Fund XYZ which charges a sales load of 5.75 percent with operating expenses of 0.68% annually. The client will immediately pay a one-time fee of $2,875 on the trade on top of the recurring fund management fee. In this case the suitability standard has been met. Client B contacts his Registered Investment Advisor with the same request. The investment advisor purchases an ETF with a gross expense ratio of 0.18 percent and pays a commission of $8.95 on the trade. This client pays his RIA a management fee of 1 percent of the assets, which equates to $500 per year on $50,000. The advisor has met the fiduciary standard. In our very realistic example, the front loaded fees paid by client A are significant enough that it would require a commitment of approximately nine years to this fund family before that commission is equal to the sum of advisory fees paid by client B.
• Question 2: Can your advisor provide a detailed explanation of how they are compensated? Do they receive commissions on any of the investments they will be recommending? Beyond "commissions," compensation can come from sales charges on mutual funds or from a higher operating expense on a specific class of funds. A registered investment advisor such as OJM typically has access to an institutional class of funds that will charge a lower expense than the retail shares commonly offered by brokers. Private equities, structured notes, hedge funds and non-traded REITs can offer various fees arrangements that may not be transparent. These investments may have a higher point of entry for an investor under the brokerage model in order to compensate the sales person facilitating the transaction. A registered investment advisor operating under the fiduciary standard may be able to offer the same investment at a lower cost simply due to the fact that they are not taking a cut before your money goes to work for you.
Example: Client A is approached by his broker to invest in a non-publicly traded real estate investment trust. The client sends in a check for $100,000, and the security is priced at $10 per share, thus the client receives 10,000 shares. The broker receives a 7 percent commission from the real estate investment trust sponsor. Client B is approached by his RIA to invest $100,000 in the same privately held REIT. The advisor charges a 1 percent management fee and does not accept compensation from the REIT sponsor. In this scenario, the commission is returned to the RIA client in the form of a reduced purchase price for the shares. Client B receives a discounted price of $9.30 from the sponsor and is able to purchase 10,752 shares of the same REIT with his $100,000 investment. Client A would be required to hold the investment for approximately 7 years before his 7 percent commission matches the sum of fees paid by client B to his advisor.
This is not a complete list of the questions you should be asking your current or prospective advisor. One of our objectives in this article was to help you identify the potential conflicts of interest in a traditional brokerage relationship. A registered investment advisor such as OJM Group typically charges a fee that represents a percentage of the assets managed and does not receive compensation from the investments that are recommended. Our hope is that by asking the questions above, investors will have a greater understanding of the potential factors that may influence the recommendations of their advisor.
In part II of this article we will provide three additional questions to help you assess the nature of you relationship with your financial professional.
1 “Why I am Leaving Goldman Sachs;” Smith, Greg, New York Times, March 12, 2012 accessed on April 2, 2013 via url: http://www.nytimes.com/2012/03/14/opinion/why-i-am-leaving-goldman-sachs.html?pagewanted=all&_r=0
2“You Charge What?,” Gleason, Jerry: Wealth Management.com accessed on October 15, 2013via url: http://wealthmanagement.com/practice-management/you-charge-what
SPECIAL OFFERS: For a free hardcopy of For Doctors Only: A Guide to Working Less & Building More, please call (877) 656-4362. If you would like a free, shorter eBook version of For Doctors Only, please download our “highlights” edition at www.fordoctorsonlyhighlights.com.
David B. Mandell, JD, MBA, is an attorney and author of five national books for doctors, including FOR DOCTORS Only: A Guide to Working Less & Building More, as well a number of state books. He is a principal of the financial consulting firm OJM Group (www.ojmgroup.com), where Andrew Taylor, CFP® works as an investment advisor. They can be reached at 877-656-4362 or firstname.lastname@example.org.
OJM Group, LLC. (“OJM”) is an SEC registered investment adviser with its principal place of business in the State of Ohio. OJM and its representatives are in compliance with the current notice filing and registration requirements imposed upon registered investment advisers by those states in which OJM maintains clients. OJM may only transact business in those states in which it is registered, or qualifies for an exemption or exclusion from registration requirements. For information pertaining to the registration status of OJM, please contact OJM or refer to the Investment Adviser Public Disclosure web site (www.adviserinfo.sec.gov).
For additional information about OJM, including fees and services, send for our disclosure brochure as set forth on Form ADV using the contact information herein. Please read the disclosure statement carefully before you invest or send money.
This article contains general information that is not suitable for everyone. The information contained herein should not be construed as personalized legal or tax advice. There is no guarantee that the views and opinions expressed in this article will be appropriate for your particular circumstances. Tax law changes frequently, accordingly information presented herein is subject to change without notice. You should seek professional tax and legal advice before implementing any strategy discussed herein.
CIRCULAR 230 DISCLOSURE: IN COMPLIANCE WITH TREASURY DEPARTMENT REQUIREMENTS, WE INFORM YOU THAT ANY FEDERAL TAX ADVICE CONTAINED IN THIS ARTICLE IS NOT INTENDED, AND CANNOT BE USED, FOR THE PURPOSE OF (A) AVOIDING PENALTIES UNDER THE INTERNAL REVENUE CODE OR (B) PROMOTING, MARKETING OR RECOMMENDING TO ANY OTHER PARTY ANY TRANSACTION OR MATTER SET FORTH HEREIN.
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- PENTAX Medical launches OPTIVISTA video processor in the US, Medigus' MUSE system safe for long-term GERD treatment & more — 14 GI company key notes
- GI physicians, PCPs have differing reasons for recommending surveillance colonoscopy to seniors: 5 findings
- Approximately 50% of Crohn's disease patients receiving STELARA achieved clinical remission: 4 insights from a new study
- VA proposes rule to allow CRNAs to expand scope of practice: 5 notes
- Thank you for downloading "Consumerism Is Here: The Art & Science of Acquiring New Patients"